These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14219480)

  • 21. [STUDIES ON INJECTIONS OF WEAK LIVE POLIOVIRUS VACCINE INTO CHILDREN. 1. RESULTS IN ISOLATION OF THE VIRUS FROM THE FECES OF INFANTS ADMITTED TO THE CHILDREN'S HOSPITAL].
    KAMIYA K
    Nihon Shonika Gakkai Zasshi; 1963 Oct; 67():702-8. PubMed ID: 14093739
    [No Abstract]   [Full Text] [Related]  

  • 22. [ORAL POLIOMYELITIS VACCINATION. ITS PRINCIPLE, USES AND METHODS FOR EXPLAINING POSSIBLE SIDE-EFFECTS].
    HAAS R
    Hippokrates; 1963 Nov; 34():843-51. PubMed ID: 14095927
    [No Abstract]   [Full Text] [Related]  

  • 23. [STUDIES ON INJECTIONS OF WEAK LIVE POLIOVIRUS VACCINE INTO CHILDREN. 2. RESULTS IN ISOLATION OF THE VIRUS FROM THE FECES IN THE INOCULATED INFANTS OF FAMILIES IN MOUNTAIN VILLAGES].
    KAMIYA K
    Nihon Shonika Gakkai Zasshi; 1963 Oct; 67():709-13. PubMed ID: 14093740
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral poliovirus vaccination program in central New York State, 1961.
    ALBRECHT RM; BIGWOOD DE Jr LEVY WC; QUINLIVAN JJ; ROGERS EF; WESTMAN ER
    Public Health Rep (1896); 1963 May; 78(5):403-12. PubMed ID: 14011771
    [No Abstract]   [Full Text] [Related]  

  • 25. THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN.
    PAGANO JS; BOETTIGER M; BONNEVIER JO; GARD S
    Am J Hyg; 1964 Jan; 79():74-85. PubMed ID: 14114357
    [No Abstract]   [Full Text] [Related]  

  • 26. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 27. [EXPERIENCES WITH A NEW ATTENUATED POLIOVIRUS TYPE 3 USOL-D BAC DEVELOPED IN CZECHOSLOVAKIA].
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H; ADAMOVA V; STAREK M
    Cesk Epidemiol Mikrobiol Imunol; 1964 Nov; 13():358-69. PubMed ID: 14241623
    [No Abstract]   [Full Text] [Related]  

  • 28. THE FEEDING OF ORAL POLIOVIRUS VACCINE TO A CLOSED COMMUNITY EXCRETING FAECAL VIRUSES.
    GARDNER PS; COOPER CE
    J Hyg (Lond); 1964 Jun; 62(2):171-8. PubMed ID: 14171269
    [No Abstract]   [Full Text] [Related]  

  • 29. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 30. [MASS VACCINATION CAMPAIGN WITH ATTENUATED LIVE POLIOVIRUS AND PROBLEMS POSED BY ITS PLANNING].
    COURTOIS G; DEWEVER A
    Brux Med; 1964 Apr; 44():415-26. PubMed ID: 14144529
    [No Abstract]   [Full Text] [Related]  

  • 31. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F; SIBONI K; GODTFREDSEN A; VON MAGNUS
    Fra Sundhedsstyr; 1963 Oct; 125():72-3. PubMed ID: 14095905
    [No Abstract]   [Full Text] [Related]  

  • 32. Enterovirus surveillance following a community-wide oral poliovirus vaccination program: a seven-year study.
    Horstmann DM; Emmons J; Gimpel L; Subrahmanyan T; Riordan JT
    Am J Epidemiol; 1973 Mar; 97(3):173-86. PubMed ID: 4348244
    [No Abstract]   [Full Text] [Related]  

  • 33. [PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].
    HENIGST W; MUELLER F; WUERSCHING F
    Z Hyg Infektionskr; 1963 Dec; 149():383-400. PubMed ID: 14123271
    [No Abstract]   [Full Text] [Related]  

  • 34. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. I. SCHEDULE OF THIS TRIAL AND EXCRETION OF VIRUS IN FECES AFTER THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    URASAWA S; OGAWA M; KANNO T
    Sapporo Igaku Zasshi; 1963 Mar; 23():194-201. PubMed ID: 14057342
    [No Abstract]   [Full Text] [Related]  

  • 35. Serodifferentiation of poliovirus strains for studies of oral vaccine.
    GELFAND HM; NAKANO JH; COLE JT
    Public Health Rep (1896); 1962 Nov; 77(11):941-6. PubMed ID: 13947055
    [No Abstract]   [Full Text] [Related]  

  • 36. COMPARATIVE SEROLOGICAL STUDIES ON THE EFFECTIVENESS OF MONOVALENT LIVE POLIOVIRUS VACCINES GIVEN ALTERNATIVELY IN THE ORDER 2-3-1 AND 1-3-2.
    FORNOSI F; TALOS I
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():263-9. PubMed ID: 14267556
    [No Abstract]   [Full Text] [Related]  

  • 37. POLIOVIRUS VARIATION AND THE PRODUCTION OF ATTENUATED STRAINS FOR VACCINES.
    HOSKINS JM
    Curr Med Drugs; 1963 Apr; 3(8):15-21. PubMed ID: 14087455
    [No Abstract]   [Full Text] [Related]  

  • 38. POLIOVIRUS ANTIBODY TWO YEARS AFTER ORAL TRIVALENT VACCINE (SABIN STRAINS).
    CABASSO VJ; NOZELL H; RUEGSEGGER JM; COX HR
    JAMA; 1964 Oct; 190():248-50. PubMed ID: 14246605
    [No Abstract]   [Full Text] [Related]  

  • 39. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 40. A MASS VACCINATION CAMPAIGN AGAINST POLIOMYELITIS USING THE SABIN ORAL VACCINE.
    FRANKLIN GC; ROBERTSON MJ
    Public Health; 1965 Jan; 79():81-99. PubMed ID: 14251614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.